SLC38A11 and neoplasm: Most ES expressed neurexin-1 (96%) and ELFN2 (96%), whereas SLC38A11 and CCDC190 were detected in just 41% and 67% of the tumours examined, respectively (Table 3 and Additional file 8, Table S5).